4/A: Astronics CEO Exercises Options, Adjusts Holdings
Insider Transaction Report Amendment
Astronics Corp's President and CEO, Peter J. Gundermann, reported exercising stock options and subsequent tax-related share withholdings, adjusting his beneficial ownership.
Summary
- Peter J. Gundermann, President and CEO of Astronics Corp, exercised stock options on November 20, 2025.
- He acquired 13,700 shares of common stock at an exercise price of $27.72 per share.
- He also acquired 4,418 shares of Class B stock at an exercise price of $27.72 per share.
- To cover withholding taxes related to the option exercise, 11,707 shares of common stock were disposed of at a price of $49.35 per share.
- Following these transactions, Gundermann directly beneficially owns 83,906.608 shares of common stock and 747,911 shares of Class B stock.
- He holds various unexercised stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates extending to December 2034.
- He also holds Restricted Stock Units (RSUs) with vesting contingent on Astronics Corp.'s average annual adjusted EBITDA for periods ending December 31, 2025, December 31, 2026, and December 31, 2027.
Sentiment
Score: 6
Explanation: The filing reports routine insider transactions, including option exercises which are generally positive as they indicate an executive realizing value from prior grants. The subsequent tax-related sale is also standard. The existence of performance-based RSUs ties executive compensation to future company performance, which is a positive governance aspect. No overtly negative or positive news beyond the mechanics of compensation.
Positives
- The CEO exercising options indicates confidence in the company's future value, as he is buying shares at a set price.
- The exercise price of $27.72 is significantly lower than the $49.35 price at which shares were withheld for taxes, indicating a substantial in-the-money gain for the CEO.
Negatives
- The disposition of 11,707 shares, while for tax purposes, reduces the CEO's direct common stock holdings.
Risks
- Vesting of a significant portion of the CEO's Restricted Stock Units (RSUs) is contingent on Astronics Corp.'s future average annual adjusted EBITDA performance, introducing performance risk.
- The actual number of RSUs vesting can vary significantly (e.g., 75%-115% or 50%-150% of target) based on performance, impacting the CEO's ultimate equity compensation.
Future Outlook
The vesting of a significant portion of the CEO's Restricted Stock Units is tied to Astronics Corp.'s future average annual adjusted EBITDA performance for the periods ending December 31, 2025, December 31, 2026, and December 31, 2027. The actual number of units vesting will range from 50% to 150% (or 75% to 115% for one tranche) of the target based on achieving specific performance thresholds.
Industry Context
This filing details routine insider transactions related to equity compensation, specifically the exercise of stock options and subsequent tax-related share dispositions by a key executive. Such transactions are common across industries as part of executive compensation packages and do not inherently reflect broader industry trends or competitive positioning, though the underlying stock performance (implied by the in-the-money options) could be influenced by industry factors.
Comparison to Industry Standards
- This filing reports standard equity compensation transactions (option exercise, RSU vesting conditions) for a public company executive.
- The structure of performance-based RSUs tied to EBITDA is a common practice in executive compensation across various industries, including aerospace and defense, which Astronics Corp operates in.
- Without specific details on Astronics' EBITDA targets or peer compensation structures, a direct comparison to specific comparable companies or projects is not feasible from this filing alone.
- The use of long-term incentives like options and performance-based RSUs aligns with general industry standards for aligning executive interests with shareholder value.
Stakeholder Impact
- Shareholders: The exercise of options by the CEO could be viewed positively as it signals confidence and aligns executive interests with shareholder value. The subsequent sale for tax purposes is a common and expected event. The performance-based RSUs align executive incentives with long-term company performance, potentially benefiting shareholders.
- Employees: No direct impact on general employees is mentioned.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is mentioned.
Next Steps
- Vesting of 9,206 target Restricted Stock Units on February 23, 2026, contingent on 2023-2025 average annual adjusted EBITDA.
- Vesting of 26,450 target Restricted Stock Units on February 23, 2027, contingent on 2024-2026 average annual adjusted EBITDA.
- Vesting of 25,250 target Restricted Stock Units on February 27, 2028, contingent on 2025-2027 average annual adjusted EBITDA.
Key Dates
| Date | Description |
|---|---|
| 12/03/2016 | Date options became exercisable for 13,700 common shares and 4,418 Class B shares. |
| 12/14/2017 | Date options became exercisable for 14,460 common shares and 2,169 Class B shares. |
| 12/12/2018 | Date options became exercisable for 26,300 common shares and 3,945 Class B shares. |
| 12/13/2019 | Date options became exercisable for 34,790 common shares. |
| 12/09/2020 | Date options became exercisable for 61,200 common shares. |
| 01/22/2022 | Date options became exercisable for 98,900 common shares. |
| 12/09/2022 | Date options became exercisable for 115,800 common shares. |
| 12/16/2023 | Date options became exercisable for 125,000 common shares. |
| 12/07/2024 | Date options became exercisable for 83,900 common shares. |
| 04/03/2025 | Date of original Form 4 filing. |
| 11/20/2025 | Date of stock option exercise and share disposition for tax withholding. |
| 11/24/2025 | Signature date of the reporting person's power of attorney. |
| 12/03/2025 | Expiration date for exercised options (13,700 common shares and 4,418 Class B shares). |
| 12/05/2025 | Date options became exercisable for 75,800 common shares. |
| 02/23/2026 | Vesting date for 9,206 target Restricted Stock Units (RSUs) based on 2023-2025 EBITDA. |
| 12/14/2026 | Expiration date for 14,460 common shares and 2,169 Class B shares options. |
| 02/23/2027 | Vesting date for 26,450 target Restricted Stock Units (RSUs) based on 2024-2026 EBITDA. |
| 12/12/2027 | Expiration date for 26,300 common shares and 3,945 Class B shares options. |
| 02/27/2028 | Vesting date for 25,250 target Restricted Stock Units (RSUs) based on 2025-2027 EBITDA. |
| 12/13/2028 | Expiration date for 34,790 common shares options. |
| 12/09/2029 | Expiration date for 61,200 common shares options. |
| 01/22/2031 | Expiration date for 98,900 common shares options. |
| 12/09/2031 | Expiration date for 115,800 common shares options. |
| 12/16/2032 | Expiration date for 125,000 common shares options. |
| 12/07/2033 | Expiration date for 83,900 common shares options. |
| 12/05/2034 | Expiration date for 75,800 common shares options. |
Recommendation
holdThis Form 4/A filing details routine insider transactions by the CEO, involving the exercise of stock options and subsequent share disposition for tax purposes. While the option exercise indicates the CEO realizing value from prior grants, it does not provide new fundamental information about the company's operational performance or strategic direction. The presence of performance-based Restricted Stock Units (RSUs) ties executive compensation to future EBITDA, which is a positive governance practice. However, without additional financial or operational updates, this filing alone does not warrant a change in investment stance. A 'hold' recommendation is appropriate as it reflects the lack of new material information that would significantly alter the investment thesis.
Keywords
Astronics Corp, ATRO, SEC Form 4/A, Insider Trading, Stock Options, Restricted Stock Units, CEO, Peter J. Gundermann, Beneficial Ownership, Equity Compensation, EBITDA Performance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.